China National Medicines Corporation Ltd. (SHA:600511)
China
· Delayed Price · Currency is CNY 30.35
-0.51 (-1.65%)
Feb 21, 2025, 3:00 PM CST
SHA:600511 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 22,899 | 21,594 | 21,051 | 23,789 | 37,205 | 20,590 | Upgrade
|
| Market Cap Growth | 4.22% | 2.58% | -11.51% | -36.06% | 80.69% | 15.86% | Upgrade
|
| Enterprise Value | 17,114 | 15,889 | 16,871 | 19,902 | 34,465 | 18,006 | Upgrade
|
| Last Close Price | 30.35 | 27.89 | 26.63 | 29.35 | 45.15 | 24.59 | Upgrade
|
| PE Ratio | 10.58 | 10.06 | 10.72 | 13.56 | 26.91 | 12.84 | Upgrade
|
| Forward PE | 9.50 | 8.91 | 10.01 | 12.87 | 19.84 | 11.60 | Upgrade
|
| PS Ratio | 0.45 | 0.43 | 0.46 | 0.51 | 0.92 | 0.46 | Upgrade
|
| PB Ratio | 1.38 | 1.23 | 1.33 | 1.66 | 2.84 | 1.69 | Upgrade
|
| P/TBV Ratio | 1.61 | 1.41 | 1.53 | 1.93 | 3.39 | 2.04 | Upgrade
|
| P/FCF Ratio | 14.87 | 8.36 | 9.29 | 12.77 | 30.18 | 12.18 | Upgrade
|
| P/OCF Ratio | 15.45 | 7.92 | 8.79 | 12.15 | 28.58 | 11.59 | Upgrade
|
| PEG Ratio | 1.36 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | Upgrade
|
| EV/Sales Ratio | 0.33 | 0.32 | 0.37 | 0.43 | 0.85 | 0.40 | Upgrade
|
| EV/EBITDA Ratio | 6.86 | 6.41 | 6.96 | 9.24 | 20.65 | 7.61 | Upgrade
|
| EV/EBIT Ratio | 7.44 | 6.69 | 7.28 | 9.69 | 22.01 | 7.94 | Upgrade
|
| EV/FCF Ratio | 11.12 | 6.15 | 7.45 | 10.69 | 27.96 | 10.65 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.03 | 0.03 | 0.05 | 0.06 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.27 | 0.21 | 0.21 | 0.31 | 0.46 | 0.23 | Upgrade
|
| Debt / FCF Ratio | 0.43 | 0.21 | 0.23 | 0.38 | 0.65 | 0.33 | Upgrade
|
| Asset Turnover | 1.55 | 1.60 | 1.58 | 1.76 | 1.64 | 1.95 | Upgrade
|
| Inventory Turnover | 9.91 | 11.90 | 11.53 | 13.05 | 11.63 | 12.16 | Upgrade
|
| Quick Ratio | 1.66 | 1.73 | 1.71 | 1.63 | 1.68 | 1.55 | Upgrade
|
| Current Ratio | 2.04 | 2.04 | 2.02 | 1.93 | 1.97 | 1.87 | Upgrade
|
| Return on Equity (ROE) | 13.20% | 13.98% | 14.09% | 14.05% | 11.95% | 16.52% | Upgrade
|
| Return on Assets (ROA) | 4.36% | 4.78% | 5.03% | 4.85% | 3.99% | 6.21% | Upgrade
|
| Return on Capital (ROIC) | 7.91% | 8.61% | 9.22% | 8.87% | 7.35% | 11.65% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.67% | 12.79% | 13.74% | 13.45% | 11.46% | 18.02% | Upgrade
|
| Earnings Yield | 9.45% | 9.94% | 9.33% | 7.37% | 3.72% | 7.79% | Upgrade
|
| FCF Yield | 6.72% | 11.95% | 10.76% | 7.83% | 3.31% | 8.21% | Upgrade
|
| Dividend Yield | 2.81% | 3.06% | 2.94% | 2.39% | 1.22% | 2.59% | Upgrade
|
| Payout Ratio | 34.70% | 33.07% | 31.16% | 36.36% | 44.34% | 28.55% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | 0.00% | 0.00% | -0.00% | 0.98% | 0.62% | Upgrade
|
| Total Shareholder Return | 2.81% | 3.06% | 2.94% | 2.38% | 2.20% | 3.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.